Literature DB >> 16480775

Measurement of kinetically resolved vesicular dopamine uptake and efflux using rotating disk electrode voltammetry.

Trent J Volz1, Glen R Hanson, Annette E Fleckenstein.   

Abstract

The vesicular monoamine transporter-2 (VMAT-2) sequesters cytoplasmic dopamine (DA) into vesicles for storage and subsequent release. VMAT-2 activity has traditionally been measured in small synaptic vesicles isolated from rat striatum by monitoring [3H] DA uptake and in cellular expression systems using fast scan cyclic voltammetry. This is the first report using rotating disk electrode (RDE) voltammetry to measure VMAT-2 DA uptake and efflux in small synaptic vesicles. DA uptake profiles followed mixed order kinetics with apparent zero order kinetics for the first 25 s and apparent first order kinetics thereafter. Vesicular DA uptake was temperature- and ATP-dependent and was blocked by the VMAT-2 inhibitor tetrabenazine. Initial velocities of DA uptake were kinetically resolved and displayed Michaelis-Menten kinetics with a Km and Vmax of 289 +/- 59 nM and 1.9 +/- 0.2 fmol/(s microg protein), respectively. Methamphetamine-induced DA efflux was blocked by tetrabenazine and kinetically resolved with an initial velocity of 0.54 +/- 0.08 fmol/(s microg protein). These results suggest that RDE voltammetry can be used to make kinetically resolved measurements of vesicular DA uptake and efflux and will allow the design of experiments that could reveal important information about the kinetics of VMAT-2 activity and its inhibition.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16480775     DOI: 10.1016/j.jneumeth.2006.01.002

Source DB:  PubMed          Journal:  J Neurosci Methods        ISSN: 0165-0270            Impact factor:   2.390


  17 in total

1.  4-Methylmethcathinone (mephedrone): neuropharmacological effects of a designer stimulant of abuse.

Authors:  Gregory C Hadlock; Katy M Webb; Lisa M McFadden; Pei Wen Chu; Jonathan D Ellis; Scott C Allen; David M Andrenyak; Paula L Vieira-Brock; Christopher L German; Kevin M Conrad; Amanda J Hoonakker; James W Gibb; Diana G Wilkins; Glen R Hanson; Annette E Fleckenstein
Journal:  J Pharmacol Exp Ther       Date:  2011-08-02       Impact factor: 4.030

2.  Changes in neuronal dopamine homeostasis following 1-methyl-4-phenylpyridinium (MPP+) exposure.

Authors:  Se Joon Choi; Anne Panhelainen; Yvonne Schmitz; Kristin E Larsen; Ellen Kanter; Min Wu; David Sulzer; Eugene V Mosharov
Journal:  J Biol Chem       Date:  2015-01-16       Impact factor: 5.157

3.  Whole-Transcriptome Analysis of Mouse Models with MPTP-Induced Early Stages of Parkinson's Disease Reveals Stage-Specific Response of Transcriptome and a Possible Role of Myelin-Linked Genes in Neurodegeneration.

Authors:  A Kh Alieva; V S Zyrin; M M Rudenok; A A Kolacheva; M V Shulskaya; M V Ugryumov; P A Slominsky; M I Shadrina
Journal:  Mol Neurobiol       Date:  2018-02-03       Impact factor: 5.590

Review 4.  Psychostimulant-induced alterations in vesicular monoamine transporter-2 function: neurotoxic and therapeutic implications.

Authors:  Annette E Fleckenstein; Trent J Volz; Glen R Hanson
Journal:  Neuropharmacology       Date:  2008-07-10       Impact factor: 5.250

5.  Method development and validation of an in vitro model of the effects of methylphenidate on membrane-associated synaptic vesicles.

Authors:  Trent J Volz; Sarah J Farnsworth; Glen R Hanson; Annette E Fleckenstein
Journal:  J Neurosci Methods       Date:  2008-10-17       Impact factor: 2.390

6.  Methylphenidate-induced alterations in synaptic vesicle trafficking and activity.

Authors:  Trent J Volz; Sarah J Farnsworth; Glen R Hanson; Annette E Fleckenstein
Journal:  Ann N Y Acad Sci       Date:  2008-10       Impact factor: 5.691

7.  Methylphenidate-induced increases in vesicular dopamine sequestration and dopamine release in the striatum: the role of muscarinic and dopamine D2 receptors.

Authors:  Trent J Volz; Sarah J Farnsworth; Shane D Rowley; Glen R Hanson; Annette E Fleckenstein
Journal:  J Pharmacol Exp Ther       Date:  2008-06-30       Impact factor: 4.030

8.  Cocaine alters vesicular dopamine sequestration and potassium-stimulated dopamine release: the role of D2 receptor activation.

Authors:  Sarah J Farnsworth; Trent J Volz; Glen R Hanson; Annette E Fleckenstein
Journal:  J Pharmacol Exp Ther       Date:  2008-11-26       Impact factor: 4.030

9.  NeuroAIDS, drug abuse, and inflammation: building collaborative research activities.

Authors:  Joan W Berman; Monica J Carson; Linda Chang; Brian M Cox; Howard S Fox; R Gilberto Gonzalez; Glen R Hanson; Kurt F Hauser; Wen-Zhe Ho; Jau-Shyong Hong; Eugene O Major; William F Maragos; Eliezer Masliah; Justin C McArthur; Diane B Miller; Avindra Nath; James P O'Callaghan; Yuri Persidsky; Christopher Power; Thomas J Rogers; Walter Royal
Journal:  J Neuroimmune Pharmacol       Date:  2006-11-08       Impact factor: 4.147

10.  Neuropharmacological mechanisms underlying the neuroprotective effects of methylphenidate.

Authors:  T J Volz
Journal:  Curr Neuropharmacol       Date:  2008-12       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.